$ARTW
ARTS WAY MANUFACTURING CO INC Stock $artw

$artw Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-Q Financial Statement

#000143774922008961 Filed on April 14, 2022

Income Statement

Concept	2022 Q1	2021 Q4	2021 Q1
Revenue	$5.613M	$7.262M	$5.401M
YoY Change	3.93%	32.77%	7.45%
Cost Of Revenue	$4.421M	$5.169M	$4.358M
YoY Change	1.45%	-13.41%	7.64%
Gross Profit	$1.192M	$2.093M	$1.043M
YoY Change	14.33%	-518.67%	6.7%
Gross Profit Margin	21.24%	28.82%	19.31%
Selling, General & Admin	$1.495M	$1.392M	$1.290M
YoY Change	15.9%	0.18%	-3.53%
% of Gross Profit	125.4%	66.52%	123.7%
Research & Development	$134.1K	$117.9K	$120.0K
YoY Change	11.73%	-1.72%	9.09%
% of Gross Profit	11.25%	5.63%	11.51%
Depreciation & Amortization	$167.5K	$159.7K	$161.1K
YoY Change	3.99%	-6.05%	-29.17%
% of Gross Profit	14.05%	7.63%	15.45%
Operating Expenses	$1.629M	$1.510M	$1.411M
YoY Change	15.44%	0.69%	-2.46%
Operating Profit	-$436.9K	$583.0K	-$368.5K
YoY Change	18.55%	-129.15%	-21.54%
Interest Expense	$76.70K	-$89.57K	$58.68K
YoY Change	30.71%	27.96%	-29.53%
% of Operating Profit		-15.36%
Other Income/Expense, Net	-$78.26K	$20.29K	-$31.03K
YoY Change	152.22%	-98.28%	-58.11%
Pretax Income	-$515.1K	$513.7K	-$399.6K
YoY Change	28.93%	-157.71%	-26.52%
Income Tax	-$108.6K	$106.3K	-$84.31K
% Of Pretax Income		20.7%
Net Earnings	-$406.5K	$407.3K	-$315.2K
YoY Change	28.95%	-192.57%	-27.89%
Net Earnings / Revenue	-7.24%	5.61%	-5.84%
Basic Earnings Per Share	-$0.09		-$0.07
Diluted Earnings Per Share	-$0.09	$89.84K	-$0.07
COMMON SHARES
Basic Shares Outstanding	4.570M	4.534M	4.475M
Diluted Shares Outstanding	4.570M		4.475M

Balance Sheet

Concept	2022 Q1	2021 Q4	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.460K	$2.660K	$0.00
YoY Change
Cash & Equivalents	$3.461K	$2.658K	$3.890K
Short-Term Investments
Other Short-Term Assets	$627.5K	$121.2K	$295.7K
YoY Change	112.18%	97.72%	12.69%
Inventory	$9.700M	$9.210M	$7.902M
Prepaid Expenses
Receivables	$1.583M	$2.663M	$1.681M
Other Receivables	$0.00	$0.00	$20.00K
Total Short-Term Assets	$12.06M	$12.17M	$10.19M
YoY Change	18.34%	18.18%	-20.8%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.261M	$5.237M	$5.223M
YoY Change	0.74%	0.36%	-4.16%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$278.4K	$299.0K	$81.64K
YoY Change	241.01%	218.94%	-21.63%
Total Long-Term Assets	$8.792M	$8.680M	$8.591M
YoY Change	2.34%	2.1%	5.63%
TOTAL ASSETS
Total Short-Term Assets	$12.06M	$12.17M	$10.19M
Total Long-Term Assets	$8.792M	$8.680M	$8.591M
Total Assets	$20.85M	$20.85M	$18.78M
YoY Change	11.02%	10.91%	-10.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.554M	$1.737M	$1.768M
YoY Change	-12.13%	-11.16%	13.75%
Accrued Expenses	$1.019M	$1.162M	$1.198M
YoY Change	-14.99%	-9.14%	8.43%
Deferred Revenue	$1.895M	$278.5K	$1.377M
YoY Change	37.56%	40.5%	519.71%
Short-Term Debt	$3.151M	$4.075M	$1.880M
YoY Change	67.58%	72.65%	-51.04%
Long-Term Debt Due	$102.7K	$99.46K	$91.34K
YoY Change	12.48%	4.72%	5.59%
Total Short-Term Liabilities	$8.094M	$7.687M	$6.432M
YoY Change	25.85%	24.69%	-11.55%
LONG-TERM LIABILITIES
Long-Term Debt	$2.613M	$2.635M	$2.699M
YoY Change	-3.18%	-2.86%	15.9%
Other Long-Term Liabilities	$31.61K	$34.93K	$20.00K
YoY Change	58.05%	74.65%	-33.33%
Total Long-Term Liabilities	$2.613M	$2.635M	$2.699M
YoY Change	-3.18%	-2.86%	15.9%
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.094M	$7.687M	$6.432M
Total Long-Term Liabilities	$2.613M	$2.635M	$2.699M
Total Liabilities	$10.87M	$10.50M	$9.147M
YoY Change	18.83%	18.02%	-4.97%
SHAREHOLDERS EQUITY
Retained Earnings	$6.250M	$6.656M	$6.129M
YoY Change	1.98%	3.3%	-24.43%
Common Stock	$46.75K	$45.84K	$45.64K
YoY Change	2.44%	2.54%	4.31%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$143.4K	$108.5K	$96.35K
YoY Change	48.86%	39.04%	45.72%
Treasury Stock Shares	$54.94K	$44.53K	$40.67K
Shareholders Equity	$9.983M	$10.35M	$9.635M
YoY Change
Total Liabilities & Shareholders Equity	$20.85M	$20.85M	$18.78M
YoY Change	11.02%	10.91%	-10.56%

Cashflow Statement

Concept	2022 Q1	2021 Q4	2021 Q1
OPERATING ACTIVITIES
Net Income	-$406.5K	$407.3K	-$315.2K
YoY Change	28.95%	-192.57%	-27.89%
Depreciation, Depletion And Amortization	$167.5K	$159.7K	$161.1K
YoY Change	3.99%	-6.05%	-29.17%
Cash From Operating Activities	$1.169M	$261.9K	$681.3K
YoY Change	71.56%	-152.38%	-170.96%
INVESTING ACTIVITIES
Capital Expenditures	$174.1K	-$132.8K	$163.9K
YoY Change	6.23%	65.95%	-38.64%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$12.81K	$10.00K
YoY Change	-100.0%	28.1%
Cash From Investing Activities	-$174.1K	-$120.0K	-$155.9K
YoY Change	11.68%	71.37%	-41.36%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$34.91K		$18.30K
YoY Change	90.78%		-4.03%
Debt Paid & Issued, Net	$23.03K		$21.87K
YoY Change	5.29%		5.28%
Cash From Financing Activities	-$993.9K	-247.3K	-$524.2K
YoY Change	89.61%	-143.38%	-142.75%
NET CHANGE
Cash From Operating Activities	$1.169M	261.9K	$681.3K
Cash From Investing Activities	-$174.1K	-120.0K	-$155.9K
Cash From Financing Activities	-$993.9K	-247.3K	-$524.2K
Net Change In Cash	$803.00	-105.3K	$1.206K
YoY Change	-33.42%	-90486370992128110.0%	749.3%
FREE CASH FLOW
Cash From Operating Activities	$1.169M	$261.9K	$681.3K
Capital Expenditures	$174.1K	-$132.8K	$163.9K
Free Cash Flow	$994.7K	$394.7K	$517.4K
YoY Change	92.26%	-193.97%	-142.16%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	4630097
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	26748	USD
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	38188	USD
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	34905	USD
CY2021Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	18296	USD
CY2022Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	54938
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	44532
CY2022Q1	artw	Standard Product Warranty Term StandardProductWarrantyTerm	P1Y
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	278411	USD
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000
CY2022Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	9500000
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	9500000
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4674671
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4583504
CY2022Q1	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	0	USD
CY2021Q1	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	0	USD
CY2021Q1	us-gaap	Due From Related Parties DueFromRelatedParties	0	USD
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	0
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3461	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2658	USD
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1582564	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2663030	USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	9700315	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	9210103	USD
CY2022Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	145640	USD
CY2021Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	177284	USD
CY2022Q1	us-gaap	Other Assets Current OtherAssetsCurrent	627464	USD
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	121170	USD
CY2022Q1	us-gaap	Assets Current AssetsCurrent	12059444	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	12174245	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5261388	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5237328	USD
CY2022Q1	artw	Assets Held For Lease Net AssetsHeldForLeaseNet	521555	USD
CY2021Q4	artw	Assets Held For Lease Net AssetsHeldForLeaseNet	521555	USD
CY2022Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	2730925	USD
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	2621886	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	299034	USD
CY2022Q1	us-gaap	Assets Assets	20851723	USD
CY2021Q4	us-gaap	Assets Assets	20854048	USD
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1553729	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1737091	USD
CY2022Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1894785	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	278509	USD
CY2022Q1	artw	Contract With Customer Liability Current Billing In Excess Of Cost And Profit ContractWithCustomerLiabilityCurrentBillingInExcessOfCostAndProfit	368514	USD
CY2021Q4	artw	Contract With Customer Liability Current Billing In Excess Of Cost And Profit ContractWithCustomerLiabilityCurrentBillingInExcessOfCostAndProfit	280761	USD
CY2022Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	5000	USD
CY2021Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	5500	USD
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1018558	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1210964	USD
CY2022Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	3150530	USD
CY2021Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	4074530	USD
CY2022Q1	us-gaap	Loans Payable Current LoansPayableCurrent	102739	USD
CY2021Q4	us-gaap	Loans Payable Current LoansPayableCurrent	99462	USD
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	8093855	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	7686817	USD
CY2022Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	129864	USD
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	142386	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	31612	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	34931	USD
CY2022Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2613375	USD
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2635467	USD
CY2022Q1	us-gaap	Liabilities Liabilities	10868706	USD
CY2021Q4	us-gaap	Liabilities Liabilities	10499601	USD
CY2022Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	46747	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	45835	USD
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3829701	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3760649	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	6249998	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	6656487	USD
CY2022Q1	us-gaap	Treasury Stock Value TreasuryStockValue	143429	USD
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	108524	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	9983017	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	10354447	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	20851723	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	20854048	USD
CY2022Q1	us-gaap	Revenues Revenues	5613066	USD
CY2021Q1	us-gaap	Revenues Revenues	5400572	USD
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4420922	USD
CY2021Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4357894	USD
CY2022Q1	us-gaap	Gross Profit GrossProfit	1192144	USD
CY2021Q1	us-gaap	Gross Profit GrossProfit	1042678	USD
CY2022Q1	artw	Engineering Expense EngineeringExpense	134071	USD
CY2021Q1	artw	Engineering Expense EngineeringExpense	121391	USD
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	487156	USD
CY2021Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	472974	USD
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1007793	USD
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	816836	USD
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	1629020	USD
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	1411201	USD
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-436876	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-368523	USD
CY2022Q1	us-gaap	Interest Expense InterestExpense	76704	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	58684	USD
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1552	USD
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	27657	USD
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-78256	USD
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-31027	USD
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-515132	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-399550	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-108643	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-84312	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-406489	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-315238	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	9906745	USD
CY2022Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-0	USD
CY2021Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	8000	USD
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	167542	USD
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	1616276	USD
CY2021Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	1179196	USD
CY2022Q1	us-gaap	Increase Decrease In Income Taxes IncreaseDecreaseInIncomeTaxes	-500	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	43758	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-315238	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	9635265	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	10354447	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	35059	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-406489	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	9983017	USD
CY2022Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-406489	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-315238	USD
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	69964	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	62054	USD
CY2022Q1	us-gaap	Inventory Write Down InventoryWriteDown	-140485	USD
CY2021Q1	us-gaap	Inventory Write Down InventoryWriteDown	-216795	USD
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	161107	USD
CY2022Q1	artw	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities Accrued Interest On Deferred Debt Payments AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAccruedInterestOnDeferredDebtPayments	4213	USD
CY2021Q1	artw	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities Accrued Interest On Deferred Debt Payments AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAccruedInterestOnDeferredDebtPayments	4161	USD
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-11440	USD
CY2021Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	25201	USD
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-109039	USD
CY2021Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-97413	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1091906	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-684378	USD
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	349727	USD
CY2021Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-76951	USD
CY2022Q1	us-gaap	Increase Decrease In Leasing Receivables IncreaseDecreaseInLeasingReceivables	-0	USD
CY2021Q1	us-gaap	Increase Decrease In Leasing Receivables IncreaseDecreaseInLeasingReceivables	-14069	USD
CY2022Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	506294	USD
CY2021Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	225977	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-183362	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-187110	USD
CY2022Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	119397	USD
CY2021Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-397920	USD
CY2021Q1	us-gaap	Increase Decrease In Income Taxes IncreaseDecreaseInIncomeTaxes	3900	USD
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-193146	USD
CY2021Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-81262	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1168816	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	681302	USD
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	174133	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	163927	USD
CY2022Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	8000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-174133	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-155927	USD
CY2022Q1	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-924000	USD
CY2021Q1	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-484000	USD
CY2022Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	11946	USD
CY2021Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	-0	USD
CY2022Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	23029	USD
CY2021Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	21873	USD
CY2022Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	2934401	USD
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	3088739	USD
CY2022Q1	us-gaap	Inventory Gross InventoryGross	11898764	USD
CY2021Q4	us-gaap	Inventory Gross InventoryGross	11735846	USD
CY2022Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	2198449	USD
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	2525743	USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	9700315	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	9210103	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-993880	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-524169	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	803	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1206	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2658	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2684	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3461	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3890	USD
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	69754	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	48826	USD
CY2022Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
CY2021Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
CY2022Q1	us-gaap	Nature Of Operations NatureOfOperations	<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;"><tbody><tr><td style="width:18pt;"> </td><td style="vertical-align:top;width:18pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><em style="font: inherit;">1</em>)</b></p> </td><td style="vertical-align:top;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Description of the Company</b></p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;">Unless otherwise specified, as used in this Quarterly Report on Form <em style="font: inherit;">10</em>-Q, the terms “we,” “us,” “our,” “Art’s-Way,” and the “Company” refer to Art’s-Way Manufacturing Co., Inc., a Delaware corporation headquartered in Armstrong, Iowa, and its wholly-owned subsidiaries.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;">The Company began operations as a farm equipment manufacturer in <em style="font: inherit;">1956.</em> Since that time, it has become a major worldwide manufacturer of agricultural equipment. Its principal manufacturing plant is located in Armstrong, Iowa.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;">The Company has organized its business into three operating segments. Management separately evaluates the financial results of each segment because each is a strategic business unit offering different products and requiring different technology and marketing strategies. The Agricultural Products segment manufactures and sells farm equipment and related replacement parts under the Art’s-Way Manufacturing label and private labels. The Modular Buildings segment manufactures and installs modular buildings for animal containment and various laboratory uses, and the Tools segment manufactures steel cutting tools and inserts.</p>
CY2022Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	pure
CY2022Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;"><i>Estimates</i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities and the reported amounts of revenue and expenses during the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> February 28, 2022. </em>Actual results could differ from those estimates.</p>
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	5613000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	5401000	USD
CY2022Q1	us-gaap	Accounts Receivable Billed For Long Term Contracts Or Programs AccountsReceivableBilledForLongTermContractsOrPrograms	1583000	USD
CY2021Q4	us-gaap	Accounts Receivable Billed For Long Term Contracts Or Programs AccountsReceivableBilledForLongTermContractsOrPrograms	2663000	USD
CY2022Q1	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	146000	USD
CY2021Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	177000	USD
CY2022Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2263000	USD
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	559000	USD
CY2022Q1	artw	Contract With Customer Liability Revenue Recognized During Period ContractWithCustomerLiabilityRevenueRecognizedDuringPeriod	415000	USD
CY2021Q1	artw	Contract With Customer Liability Revenue Recognized During Period ContractWithCustomerLiabilityRevenueRecognizedDuringPeriod	265000	USD
CY2022Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	0	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-406489	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-315238	USD
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4569720
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4475279
CY2022Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
CY2021Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4569720
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4475279
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
CY2022Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	8418441	USD
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	8289386	USD
CY2022Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	545922	USD
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	357721	USD
CY2022Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	280512	USD
CY2022Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	622984	USD
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	654757	USD
CY2022Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	115062	USD
CY2021Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	202850	USD
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	353357	USD
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1018558	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1210964	USD
CY2022Q1	us-gaap	Property Subject To Or Available For Operating Lease Gross PropertySubjectToOrAvailableForOperatingLeaseGross	521555	USD
CY2021Q4	us-gaap	Property Subject To Or Available For Operating Lease Gross PropertySubjectToOrAvailableForOperatingLeaseGross	521555	USD
CY2022Q1	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	0	USD
CY2021Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	202850	USD
CY2020Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	291453	USD
CY2022Q1	artw	Standard Product Warranty Accrual Decrease Increase For Payments And Adjustments StandardProductWarrantyAccrualDecreaseIncreaseForPaymentsAndAdjustments	-21624	USD
CY2021Q1	artw	Standard Product Warranty Accrual Decrease Increase For Payments And Adjustments StandardProductWarrantyAccrualDecreaseIncreaseForPaymentsAndAdjustments	-33506	USD
CY2022Q1	artw	Standard Product Warranty Accrual Increase Decrease For Warranties Issued And Cancelled StandardProductWarrantyAccrualIncreaseDecreaseForWarrantiesIssuedAndCancelled	-109412	USD
CY2021Q1	artw	Standard Product Warranty Accrual Increase Decrease For Warranties Issued And Cancelled StandardProductWarrantyAccrualIncreaseDecreaseForWarrantiesIssuedAndCancelled	-29378	USD
CY2022Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	115062	USD
CY2021Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	295581	USD
CY2022Q1	us-gaap	Long Term Debt LongTermDebt	2716114	USD
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	2734929	USD
CY2022Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	102739	USD
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	99462	USD
CY2022Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2613375	USD
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2635467	USD
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	101362	USD
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	108284	USD
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	113444	USD
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	119552	USD
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	125630	USD
CY2022Q1	artw	Longterm Debt Maturity Year Four And Thereafter LongtermDebtMaturityYearFourAndThereafter	2147842	USD
CY2022Q1	us-gaap	Long Term Debt LongTermDebt	2716114	USD
CY2022Q1	us-gaap	Due From Related Parties DueFromRelatedParties	0	USD
CY2022Q1	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	9349	USD
CY2021Q1	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	4669	USD
CY2022Q1	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	1299	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	11162	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	9532	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	4764	USD
CY2022Q1	us-gaap	Lease Cost LeaseCost	4843	USD
CY2021Q1	us-gaap	Lease Cost LeaseCost	6080	USD
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P46M
CY2022Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0488	pure
CY2021Q1	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	1353	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	44639	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	47794	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	13027	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	12863	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	31612	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	34931	USD
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	44639	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	47794	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	11186	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	12345	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	48989	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	4350	USD
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	44639	USD
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	174526	USD
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	190667	USD
CY2022Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	49169	USD
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	48591	USD
CY2022Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	129864	USD
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	142386	USD
CY2022Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	179033	USD
CY2021Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	190977	USD
CY2022Q1	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	42485	USD
CY2022Q1	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	56646	USD
CY2022Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	68029	USD
CY2022Q1	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	14203	USD
CY2022Q1	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	12619	USD
CY2022Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	193982	USD
CY2022Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	14949	USD
CY2022Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	179033	USD
CY2022Q1	us-gaap	Lessee Finance Lease Term Of Contract1 LesseeFinanceLeaseTermOfContract1	P39M
CY2022Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0477	pure
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	16142	USD
CY2021Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	0	USD
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	0
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	8333
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	-0
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	91167
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	93500
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	0
CY2022Q1	artw	Share Based Compensation Expense Including Treasury Share Repurchase Expense ShareBasedCompensationExpenseIncludingTreasuryShareRepurchaseExpense	69964	USD
CY2021Q1	artw	Share Based Compensation Expense Including Treasury Share Repurchase Expense ShareBasedCompensationExpenseIncludingTreasuryShareRepurchaseExpense	62054	USD
CY2022Q1	artw	Share Based Compensation Treasury Share Repurchase Expense ShareBasedCompensationTreasuryShareRepurchaseExpense	34905	USD
CY2021Q1	artw	Share Based Compensation Treasury Share Repurchase Expense ShareBasedCompensationTreasuryShareRepurchaseExpense	18296	USD
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	35059	USD
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	42758	USD
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	pure

Files In Submission

Name	View Source	Status
0001437749-22-008961-index-headers.html	Edgar Link	pending
0001437749-22-008961-index.html	Edgar Link	pending
0001437749-22-008961.txt	Edgar Link	pending
0001437749-22-008961-xbrl.zip	Edgar Link	pending
artw-20220228.xsd	Edgar Link	pending
artw-20220228_cal.xml	Edgar Link	unprocessable
artw-20220228_def.xml	Edgar Link	unprocessable
artw-20220228_lab.xml	Edgar Link	unprocessable
artw-20220228_pre.xml	Edgar Link	unprocessable
artw20220228_10q.htm	Edgar Link	pending
artw20220228_10q_htm.xml	Edgar Link	completed
ex_357017.htm	Edgar Link	pending
ex_357018.htm	Edgar Link	pending
ex_357019.htm	Edgar Link	pending
ex_357020.htm	Edgar Link	pending
ex_357354.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
scancode.jpg	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ARTW
ARTS WAY MANUFACTURING CO INC Stock $artw

2022 Q1 Form 10-Q Financial Statement

#000143774922008961 Filed on April 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ARTW ARTS WAY MANUFACTURING CO INC Stock $artw

2022 Q1 Form 10-Q Financial Statement

#000143774922008961 Filed on April 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ARTW
ARTS WAY MANUFACTURING CO INC Stock $artw